Self-assembling multicellular bodies and methods of producing a three-dimensional biological structure using the same

US9556415B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9556415-B2
Application numberUS-201414244679-A
CountryUS
Kind codeB2
Filing dateApr 3, 2014
Priority dateJun 24, 2008
Publication dateJan 31, 2017
Grant dateJan 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Structures and methods for tissue engineering include a multicellular body including a plurality of living cells. A plurality of multicellular bodies can be arranged in a pattern and allowed to fuse to form an engineered tissue. The arrangement can include filler bodies including a biocompatible material that resists migration and ingrowth of cells from the multicellular bodies and that is resistant to adherence of cells to it. Three-dimensional constructs can be assembled by printing or otherwise stacking the multicellular bodies and filler bodies such that there is direct contact between adjoining multicellular bodies, suitably along a contact area that has a substantial length. The direct contact between the multicellular bodies promotes efficient and reliable fusion. The increased contact area between adjoining multicellular bodies also promotes efficient and reliable fusion. Methods of producing multicellular bodies having characteristics that facilitate assembly of the three-dimensional constructs are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of producing a three-dimensional biological engineered tissue, the method comprising: arranging a plurality of elongate multicellular bodies on a substrate according to a pattern such that each of the multicellular bodies contacts at least one other multicellular body, wherein each multicellular body comprises a plurality of living cells, arranging one or more filler bodies in the pattern with the multicellular bodies so that each filler body contacts at least one multicellular body or another filler body, each filler body comprising a biocompatible material that resists migration and ingrowth of cells from the multicellular bodies into the filler bodies and resists adherence of cells in the multicellular bodies to the filler bodies, allowing at least one of the multicellular bodies to fuse with at least one other multicellular body to produce a three-dimensional biological engineered tissue; and removing the one or more filler bodies. 2. The method of claim 1 , wherein the arranging comprises arranging the multicellular bodies and the filler bodies to form a three-dimensional structure having a plurality of spaces that are not occupied by the multicellular bodies and that are not occupied by the filler bodies. 3. The method of claim 1 , further comprising filling at least some of the plurality of spaces with tissue culture medium. 4. The method of claim 1 , wherein arranging the filler bodies comprises arranging filler bodies which are permeable to nutrients. 5. The method of claim 1 , wherein arranging the multicellular bodies comprises arranging multicellular bodies consisting essentially of cells of a single cell type. 6. The method of claim 1 , wherein arranging the multicellular bodies comprises arranging multicellular bodies wherein each multicellular body includes living cells of a first type and at least about 90 percent of the cells in each multicellular body are cells of the first cell type. 7. The method of claim 1 , wherein arranging the multicellular bodies comprises arranging one or more multicellular bodies comprising a plurality of living cells of a first cell type and a plurality of living cells of a second cell type, the second cell type being different from the first cell type. 8. The method of claim 7 , wherein the living cells of the first type are endothelial cells and the living cells of the second type are smooth muscle cells. 9. The method of claim 7 , wherein the living cells of the first type are smooth muscle cells and the living cells of the second type are fibroblasts. 10. The method of claim 7 , wherein the living cells of the first type are endothelial cells and the living cells of the second type are fibroblasts. 11. The method of claim 1 , wherein one or more of the multicellular bodies comprises a plurality of living cells of a first cell type, a plurality of living cells of a second type, and a plurality of living cells of a third cell type, wherein each of the first, second and third cell types are different from the others of the first, second, and third cell types. 12. The method of claim 11 , wherein, the living cells of the first cell type are endothelial cells, the living cells of the second cell type are smooth muscle cells, and the living cells of the third cell type are fibroblasts. 13. The method of claim 1 , wherein arranging the multicellular bodies comprises arranging multicellular bodies that are substantially uniform in shape. 14. The method of claim 1 , wherein arranging the filler bodies comprises arranging filler bodies that are substantially uniform in shape. 15. The method of claim 1 , wherein arranging the multicellular bodies and filler bodies comprises arranging multicellular bodies and filler bodies that are substantially identical in shape. 16. The method of claim 1 , wherein arranging the filler bodies comprises arranging filler bodies that are elongate in shape. 17. The method of claim 1 , wherein arranging the multicellular bodies comprises arranging at least some of the multicellular bodies to form a sheet. 18. The method of claim 1 , wherein arranging the multicellular bodies comprises arranging multicellular bodies wherein the cohesion of the cells in the multicellular body is sufficiently strong to allow the multicellular body to retain a three-dimensional shape while supporting itself on a flat surface, said three-dimensional shape including a width and a height, the height being at least 50 percent of the width. 19. The method of claim 1 , wherein arranging the multicellular bodies comprises arranging multicellular bodies wherein the cohesion of the cells in the multicellular body is sufficiently strong to allow the multicellular body to support the weight of another multicellular body that is substantially identical to the multicellular body when said other multicellular body is on top of the multicellular body. 20. The method of claim 1 , wherein arranging the multicellular bodies comprises arranging multicellular bodies wherein the cohesion of the cells in the multicellular body is sufficiently strong to allow the multicellular body to be picked up by an implement. 21. The method of claim 1 , wherein the arranging is automated. 22. The method of claim 1 , wherein the one or more filler bodies is removed by dissolving the filler bodies. 23. The method of claim 22 , wherein the one or more filler bodies is dissolved by change in temperature or light. 24. The method of claim 1 , wherein the plurality of living cells comprises one or more of: endothelial cells, muscle cells, fibroblasts, liver cells, kidney cells, neural cells, bone cells, cartilage cells, epithelial cells, and undifferentiated cells.

Assignees

Inventors

Classifications

  • Drugs for disorders of the cardiovascular system · CPC title

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • General methods for three-dimensional culture · CPC title

  • A61L27/222Primary

    Gelatin · CPC title

  • comprising two or more cell types · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9556415B2 cover?
Structures and methods for tissue engineering include a multicellular body including a plurality of living cells. A plurality of multicellular bodies can be arranged in a pattern and allowed to fuse to form an engineered tissue. The arrangement can include filler bodies including a biocompatible material that resists migration and ingrowth of cells from the multicellular bodies and that is resi…
Who is the assignee on this patent?
Univ Missouri
What technology area does this patent fall under?
Primary CPC classification A61L27/222. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).